2001
DOI: 10.1128/aem.67.9.4111-4118.2001
|View full text |Cite
|
Sign up to set email alerts
|

Ruminococcin A, a New Lantibiotic Produced by a Ruminococcus gnavu s Strain Isolated from Human Feces

Abstract: When cultivated in the presence of trypsin, the Ruminococcus gnavus E1 strain, isolated from a human fecal sample, was able to produce an antibacterial substance that accumulated in the supernatant. This substance, called ruminococcin A, was purified to homogeneity by reverse-phase chromatography. It was shown to be a 2,675-Da bacteriocin harboring a lanthionine structure. The utilization of Edman degradation and tandem mass spectrometry techniques, followed by DNA sequencing of part of the structural gene, al… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
111
0
6

Year Published

2002
2002
2019
2019

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 149 publications
(122 citation statements)
references
References 31 publications
(21 reference statements)
3
111
0
6
Order By: Relevance
“…All procedures were carried out according to European guidelines for the care and use of laboratory animals and with permission 78 -122 of the French Veterinary Services. The following groups of rats (male, Fisher 344) were used: germ-free (GF); conventional (CV); GF inoculated with a fecal microbiota obtained from CV rats (Ino-CV); GF-inoculated with pure bacterial strains: C. paraputrificum (strain number: 217.59) (30) isolated from the intestinal contents of CV rats (Ino-Cp); B. thetaiotaomicron (strain number: BtII8) (Ino-Bt) (11) and R. gnavus (strain number: FRE1) (Ino-Rg) (9), isolated from the fecal contents of humans.…”
Section: Methodsmentioning
confidence: 99%
“…All procedures were carried out according to European guidelines for the care and use of laboratory animals and with permission 78 -122 of the French Veterinary Services. The following groups of rats (male, Fisher 344) were used: germ-free (GF); conventional (CV); GF inoculated with a fecal microbiota obtained from CV rats (Ino-CV); GF-inoculated with pure bacterial strains: C. paraputrificum (strain number: 217.59) (30) isolated from the intestinal contents of CV rats (Ino-Cp); B. thetaiotaomicron (strain number: BtII8) (Ino-Bt) (11) and R. gnavus (strain number: FRE1) (Ino-Rg) (9), isolated from the fecal contents of humans.…”
Section: Methodsmentioning
confidence: 99%
“…As previously reported for some AMPs, including HD-5 (77,124) and some cathelicidins (212), it is interesting that two antibacterial substances produced by bacterial species in the intestinal microbiota, Peptostreptococcus sp. (325) and the R. gnavus E1 strain (78,126), require processing to be activated, after the proforms have been cleaved by trypsin.…”
Section: Barrier Effect Against Pathogensmentioning
confidence: 99%
“…Third, production of microbicidal factors is a common case of interference competition among bacteria. Numerous bacteriocins produced by the intestinal microbiota are active against potential pathogens such as Listeria, Salmonella and Clostridium species (Dabard et al, 2001;Gong et al, 2010;Rea et al, 2010). Cuticular Streptomycetes bacteria are protecting the offspring of digger wasps from fungal pathogens by producing a complex cocktail of antibiotics (Kroiss et al, 2010).…”
Section: Introductionmentioning
confidence: 99%